Sarita Kapila
Stock Analyst at Morgan Stanley
(0.78)
# 3,806
Out of 4,408 analysts
53
Total ratings
40.6%
Success rate
-4.8%
Average return
Main Sectors:
Stocks Rated by Sarita Kapila
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNY Sanofi | Downgraded: Hold | $58 → $52 | $44.25 | +17.51% | 3 | May 1, 2026 | |
| SWX: ROP Roche Holding AG | Upgraded: Hold | CHF 295.00 | $328.50 | -10.20% | 10 | Apr 24, 2026 | |
| LON: AZN AstraZeneca PLC | Maintained: Buy | 16,500p | $13,454.00 | +22.64% | 9 | Apr 13, 2026 | |
| RHHBY Roche Holding AG | Maintained: Sell | $39 → $46 | $51.65 | -10.94% | 2 | Apr 7, 2026 | |
| LON: 0NZT UCB SA | Downgraded: Hold | €260.00 | $273.80 | -5.04% | 6 | Mar 6, 2026 | |
| LON: GSK GSK plc | Maintained: Sell | 1,600p → 1,700p | $1,987.00 | -14.44% | 8 | Mar 2, 2026 | |
| EPA: SAN Sanofi | Upgraded: Buy | €100.00 | $76.48 | +30.75% | 1 | Sep 8, 2025 | |
| STO: SOBI Swedish Orphan Biovitrum AB (publ) | Maintained: Hold | kr 253.10 → kr 257.88 | $437.40 | n/a | 2 | May 4, 2023 | |
| GRFS Grifols | Maintained: Buy | $16 → $19 | $7.64 | n/a | 2 | Feb 8, 2023 | |
| BME: GRF Grifols, S.A. | Maintained: Buy | €14.00 → €16.00 | $9.26 | n/a | 6 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $36 | $44.70 | n/a | 4 | Nov 16, 2022 |
Sanofi
May 1, 2026
Downgraded: Hold
Price Target: $58 → $52
Current: $44.25
Upside: +17.51%
Roche Holding AG
Apr 24, 2026
Upgraded: Hold
Price Target: CHF 295.00
Current: $328.50
Upside: -10.20%
AstraZeneca PLC
Apr 13, 2026
Maintained: Buy
Price Target: 16,500p
Current: $13,454.00
Upside: +22.64%
Roche Holding AG
Apr 7, 2026
Maintained: Sell
Price Target: $39 → $46
Current: $51.65
Upside: -10.94%
UCB SA
Mar 6, 2026
Downgraded: Hold
Price Target: €260.00
Current: $273.80
Upside: -5.04%
GSK plc
Mar 2, 2026
Maintained: Sell
Price Target: 1,600p → 1,700p
Current: $1,987.00
Upside: -14.44%
Sanofi
Sep 8, 2025
Upgraded: Buy
Price Target: €100.00
Current: $76.48
Upside: +30.75%
Swedish Orphan Biovitrum AB (publ)
May 4, 2023
Maintained: Hold
Price Target: kr 253.10 → kr 257.88
Current: $437.40
Upside: n/a
Grifols
Feb 8, 2023
Maintained: Buy
Price Target: $16 → $19
Current: $7.64
Upside: n/a
Grifols, S.A.
Feb 8, 2023
Maintained: Buy
Price Target: €14.00 → €16.00
Current: $9.26
Upside: n/a
Nov 16, 2022
Downgraded: Hold
Price Target: $36
Current: $44.70
Upside: n/a